Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 71
Filter
1.
Colorectal Dis ; 22(1): 62-70, 2020 01.
Article in English | MEDLINE | ID: mdl-31344314

ABSTRACT

AIM: Patient body composition is an important indicator of metabolic status and is associated with cancer progression. Because body composition varies between men and women, we aimed to examine the difference in clinical impact of preoperative body composition according to sex. METHOD: We used an integrated dataset of 559 colorectal cancer (CRC) patients. The association between preoperative body composition indices [body mass index (BMI), visceral to subcutaneous fat area ratio (VSR) and skeletal muscle index (SMI)] and patient outcome, clinicopathological factors and preoperative inflammation and nutritional status was analysed, comparing men and women. RESULTS: Preoperative low BMI and low SMI in men was significantly associated with unfavourable overall survival (OS) [BMI: hazard ratio (HR) 2.22, 95% CI 1.28-4.14, P = 0.004; SMI: HR 2.54, 95% CI 1.61-4.07, P < 0.001] and high VSR in women was significantly associated with unfavourable OS (HR 1.79, 95% CI 1.03-3.02, P = 0.040). Additionally, low SMI in men was significantly associated with deeper tumour invasion and greater distant metastasis and high VSR in women was significantly associated with advanced age, right-sided tumour, lower total lymphocyte count and lower albumin levels. Interestingly, low BMI in men was significantly associated with deeper tumour invasion, but also with favourable inflammation and nutritional status (lower C-reactive protein and higher albumin). CONCLUSION: The clinical impact of preoperative body composition differed between men and women: SMI in men and VSR in women were good prognosticators. Our findings may provide a novel insight for CRC treatment strategies.


Subject(s)
Body Composition/physiology , Body Mass Index , Colorectal Neoplasms/physiopathology , Health Status Indicators , Sex Factors , Adipose Tissue/physiopathology , Aged , Colorectal Neoplasms/surgery , Female , Humans , Intra-Abdominal Fat/physiopathology , Male , Middle Aged , Muscle, Skeletal/physiopathology , Preoperative Period , Prognosis , Proportional Hazards Models , Retrospective Studies , Risk Factors
2.
Colorectal Dis ; 21(1): 100-109, 2019 01.
Article in English | MEDLINE | ID: mdl-30230148

ABSTRACT

AIM: Preoperative anaemia is associated with adverse outcomes in colorectal cancer (CRC). To clarify the reason for this we aimed to comprehensively assess the association of preoperative anaemia with tumour characteristics, host systemic inflammation and nutrition status, and perioperative blood transfusion. METHOD: We used an integrated database of 592 CRC patients. The association of preoperative anaemic subtype, calculated from haemoglobin and erythrocyte mean corpuscular volume levels, with patient outcome, preoperative serum data relating to systemic inflammation and nutrition and perioperative blood transfusion was analysed. RESULTS: Preoperative anaemia was significantly associated with poorer overall survival and relapse-free survival (RFS); in particular microcytic anaemia had a trend to poorer RFS than other forms of anaemia (P = 0.0648). In addition, preoperative anaemia was significantly correlated with right-sided tumours, greater depth of tumour invasion, use of neoadjuvant chemotherapy, poorer prognostic nutritional index and higher modified Glasgow Prognostic Score (mGPS). Microcytic anaemia in particular had a strong association with a greater depth of tumour invasion (P = 0.0072) and higher mGPS (P = 0.0058) than other causes of anaemia. Perioperative blood transfusion for CRC patients with anaemia was associated with adverse outcomes. CONCLUSIONS: Preoperative anaemia, especially microcytic anaemia, was associated with poor patient outcomes, possibly due to poor systemic inflammatory and nutritional status, and it was not improved by perioperative blood transfusion. Our data suggest that preoperative anaemia and the anaemic subtype may serve as an easily available predictor of outcome in CRC.


Subject(s)
Anemia/epidemiology , Colorectal Neoplasms/surgery , Adult , Aged , Aged, 80 and over , Anemia/classification , Anemia/metabolism , Anemia, Macrocytic/epidemiology , Anemia, Macrocytic/metabolism , Blood Transfusion , C-Reactive Protein/metabolism , Colorectal Neoplasms/pathology , Disease-Free Survival , Erythrocyte Indices , Female , Hemoglobins/metabolism , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Neoadjuvant Therapy , Neoplasm Invasiveness , Nutrition Assessment , Preoperative Period , Prognosis , Proportional Hazards Models , Serum Albumin/metabolism , Survival Rate , Treatment Outcome , Young Adult
3.
Dis Esophagus ; 31(6)2018 Jun 01.
Article in English | MEDLINE | ID: mdl-29444214

ABSTRACT

Evidence suggests that minimally invasive esophagectomy has several advantages with regard to short-term outcomes, compared to open esophagectomy in esophageal cancer patients. However, the impact of minimally invasive esophagectomy on long-term respiratory function remains unknown. The objective of this study is to assess the association between use of the minimally invasive esophagectomy and long-term respiratory dysfunction in esophageal cancer patients after esophagectomy. This retrospective single institution study using prospectively collected data included 87 consecutive esophageal cancer patients who had undergone esophagectomy. All patients underwent a respiratory function test before, and one year after esophagectomy. Logistic regression analysis was used to compute the hazard ratio for long-term respiratory dysfunction. Minimally invasive esophagectomies were performed in 53 patients, and open esophagectomies in 34 patients. The two groups showed no significant differences in terms of postoperative complications and postoperative course. Nor were any differences observed between the two groups in terms of volume capacity (L) and forced expiratory volume 1.0 (L) before esophagectomy (P > 0.34). However, one year after esophagectomy, the decreases in volume capacity and forced expiratory volume 1.0 were significantly less in the minimally invasive esophagectomy group than in the open esophagectomy group (P = 0.04 and P = 0.007, respectively). Multivariate analyses revealed that minimally invasive esophagectomy was an independent favorable factor for maintenance of forced expiratory volume 1.0 (hazard ratio = 0.17, 95% confidence interval 0.04-0.71; P = 0.01). Minimally invasive esophagectomy may be an independent favorable factor for maintenance of long-term respiratory function in esophageal cancer patients after esophagectomy.


Subject(s)
Esophageal Neoplasms/surgery , Esophagectomy/adverse effects , Postoperative Complications/etiology , Respiration Disorders/etiology , Aged , Esophageal Neoplasms/physiopathology , Esophagectomy/methods , Female , Humans , Lung/physiopathology , Male , Middle Aged , Minimally Invasive Surgical Procedures/adverse effects , Minimally Invasive Surgical Procedures/methods , Multivariate Analysis , Postoperative Period , Proportional Hazards Models , Prospective Studies , Retrospective Studies , Time , Treatment Outcome
4.
Neoplasma ; 64(1): 140-147, 2017.
Article in English | MEDLINE | ID: mdl-27881016

ABSTRACT

An increased platelet count is often observed in lung cancer patients. Whether and how the platelets affect cancer progression have yet to be established. The aim of the study was to investigate the involvement of the platelet count and mean platelet volume (MPV) in the prognosis and progression of lung cancer patients. This retrospective study included 146 patients with newly diagnosed primary lung cancer. The platelet count and MPV were measured before invasive diagnostic procedures and treatment. These platelet indices, overall survival of the patients, and tumor metastases for each organ were analyzed. On Kaplan-Meier survival analysis, the overall survivals of patients with platelet counts ≤ 244.0 × 109/L or MPV > 9.7 fL were longer than those of patients with platelet counts > 244.0 × 109/L or MPV ≤ 9.7 fL. Cox regression analysis showed that poor performance status, increased platelet count, and increased C-reactive protein were independent prognostic factors. The platelet indices were associated with metastases to bone, soft tissue, and lymph node, in addition to malignant pleural effusion. Increased platelet count and decreased MPV were unfavorable prognostic factors for patients with lung cancer, and they were involved in bone, soft tissue, and lymph node metastases and malignant pleural effusion.


Subject(s)
Lung Neoplasms/pathology , Mean Platelet Volume , Platelet Count , Pleural Effusion, Malignant/diagnosis , Bone Neoplasms/secondary , Humans , Lymph Nodes/pathology , Lymphatic Metastasis , Prognosis , Retrospective Studies , Soft Tissue Neoplasms/secondary , Survival Analysis
5.
Dis Esophagus ; 30(12): 1-9, 2017 Dec 01.
Article in English | MEDLINE | ID: mdl-28881886

ABSTRACT

Pneumonia is a major cause of postesophagectomy mortality and worsens the long-term survival in resected esophageal cancer patients. Moreover, preoperative treatments such as chemotherapy or chemoradiotherapy (which have recently been applied worldwide) might affect the bacterial flora of the sputum. To investigate the association among preoperative treatments, the bacterial flora of sputum, and the clinical and pathological features in resected esophageal cancer patients, this study newly investigates the effect of preoperative treatments on the bacterial flora of sputum. We investigated the association among preoperative treatments, the bacterial flora of sputum, and clinical and pathological features in 163 resected esophageal cancer patients within a single institution. Pathogenic bacteria such as Candida (14.1%), Staphylococcus aureus (6.7%), Enterobacter cloacae (6.1%), Haemophilus parainfluenzae (4.9%), Klebisiella pneumoniae (3.7%), Methicillin-resistant Staphylococcus aureus (MRSA) (3.7%), Pseudomonas aeruginosa (2.5%), Escherichia coli (1.8%), Streptococcus pneumoniae (1.8%), and Haemophilus influenzae (1.2%) were found in the sputum. The pathogen detection rate in the present study was 34.3% (56/163). In patients with preoperative chemotherapy and chemoradiotherapy, the indigenous Neisseria and Streptococcus species were significantly decreased (P= 0.04 and P= 0.04). However, the detection rates of pathogenic bacteria were not associated with preoperative treatments (all P> 0.07). There was not a significant difference of hospital stay between the sputum-monitored patients and unmonitored patients (35.5 vs. 49.9 days; P= 0.08). Patients undergoing preoperative treatments exhibited a significant decrease of indigenous bacteria, indicating that the treatment altered the bacterial flora of their sputum. This finding needs to be confirmed in large-scale independent studies or well-designed multicenter studies.


Subject(s)
Esophageal Neoplasms/pathology , Esophageal Neoplasms/therapy , Microbiota/drug effects , Microbiota/radiation effects , Sputum/microbiology , Aged , Candida/isolation & purification , Chemoradiotherapy, Adjuvant , Chemotherapy, Adjuvant , Enterobacter cloacae/isolation & purification , Escherichia coli/isolation & purification , Esophagectomy , Female , Haemophilus influenzae/isolation & purification , Haemophilus parainfluenzae/isolation & purification , Humans , Klebsiella pneumoniae/isolation & purification , Length of Stay , Male , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Middle Aged , Neisseria/isolation & purification , Neoadjuvant Therapy , Preoperative Period , Pseudomonas aeruginosa/isolation & purification , Retrospective Studies , Streptococcus pneumoniae/isolation & purification
6.
Dis Esophagus ; 29(6): 627-33, 2016 Aug.
Article in English | MEDLINE | ID: mdl-26123787

ABSTRACT

Recently, depletion of skeletal muscle mass (sarcopenia) has been linked to poor prognosis in several types of cancers, but has not been investigated in esophageal squamous cell carcinoma (ESCC). This retrospective study investigates the relationship between sarcopenia and clinical outcome in ESCC patients treated by surgical resection or definitive chemoradiation therapy (dCRT). The study was retrospectively conducted in a single academic hospital in Kumamoto, Japan, and involved 325 ESCC patients (256 surgical cases and 69 dCRT cases) treated between April 2005 and April 2011. Skeletal muscle mass was quantified by radiologic measures using standard computed tomography scans. The skeletal muscle tissue in the 325 ESCC patients was distributed as follows: mean: 47.10; median: 46.88; standard deviation (SD): 7.39; range: 31.48-71.11; interquartile range, 46.29-47.90. Skeletal muscle tissue was greater in male patients than in female patients (P < 0.0001), but was independent of other clinical and tumor features. Sarcopenia was not significantly associated with overall survival (log rank P = 0.54). Lymph node involvement significantly altered the relationship between sarcopenia and survival rate (P for interaction = 0.026). Sarcopenia significantly reduced the overall survival of patients without lymph node involvement (log rank P = 0.035), but was uncorrelated with overall survival in patients with lymph involvement (log rank, P = 0.31). The anastomosis leakage rate was significantly higher in the sarcopenia group than in the non-sarcopenia group (P = 0.032), but other surgical complications did not significantly differ between the two groups. Sarcopenia in ESCC patients without lymph node involvement is associated with poor prognosis, indicating sarcopenia as a potential biomarker for identifying patients likely to experience an inferior outcome. Moreover, sarcopenia was associated with anastomosis leakage but no other short-term surgical outcome.


Subject(s)
Anastomotic Leak/epidemiology , Carcinoma, Squamous Cell/mortality , Chemoradiotherapy , Esophageal Neoplasms/mortality , Esophagectomy , Sarcopenia/epidemiology , Aged , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/therapy , Esophageal Neoplasms/pathology , Esophageal Neoplasms/therapy , Esophageal Squamous Cell Carcinoma , Female , Humans , Japan/epidemiology , Lymph Nodes/pathology , Male , Middle Aged , Muscle, Skeletal/diagnostic imaging , Neoplasm Staging , Postoperative Complications/epidemiology , Prognosis , Retrospective Studies , Survival Rate , Tomography, X-Ray Computed
7.
Rev Sci Instrum ; 87(11): 11D424, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27910550

ABSTRACT

In the divertor simulation experiments in the GAMMA 10/PDX tandem mirror, pressure of the neutral gas was investigated by using a fast ionization gauge. The gauge was absolutely calibrated for hydrogen gas by using a capacitance manometer. Change of the gauge sensitivity due to the magnetic field of GAMMA 10/PDX was also evaluated. The typical gas pressure measured in detached plasma experiments was 0.1-10 Pa. The degree of plasma detachment determined from the reduction of heat flux was enhanced as the gas pressure increases. Rapid increase of the gas pressure under the plasma flow was also observed.

8.
Endocrinology ; 119(1): 125-9, 1986 Jul.
Article in English | MEDLINE | ID: mdl-2873022

ABSTRACT

The effect of chemical stimulation of the central nervous system was studied in anesthetized rats. (Bu)2 cAMP, cAMP, 5'-adenosine monophosphate (AMP), ATP, and (Bu)2 N6,O2-dibutyryl guanosine-3'5'-cyclic monophosphate sodium salt were injected directly into the third cerebral ventricle, and changes in hepatic venous plasma glucose, immunoreactive glucagon, and insulin concentrations were studied. The injection of (Bu)2cAMP (1 X 10(-8) to 5 X 10(-7) mol/microliter saline) into the third cerebral ventricle caused a dose-dependent hyperglycemia associated with increased immunoreactive glucagon. (Bu)2cAMP-induced hyperglycemia and hyperglucagonemia were inhibited by prior bilateral adrenalectomy. The injection of somatostatin (1 X 10(-9) mol) with (Bu)2cAMP (5 X 10(-7) mol) into the third cerebral ventricle abolished both (Bu)2cAMP-induced hyperglycemia and an increase of glucagon secretion. These results suggest that cAMP may act intracellularly within the central nervous system to increase hepatic glucose output, and this appears to depend on the adrenal gland. Epinephrine secreted from the adrenal gland may directly act on the liver or enhance glucagon secretion, which in turn increases hepatic glucose output.


Subject(s)
Blood Glucose/analysis , Bucladesine/pharmacology , Hyperglycemia/chemically induced , Adenosine Triphosphate/pharmacology , Animals , Atropine/pharmacology , Bucladesine/administration & dosage , Cyclic AMP/pharmacology , Dibutyryl Cyclic GMP/pharmacology , Epinephrine/pharmacology , Glucagon/blood , Hexamethonium , Hexamethonium Compounds/pharmacology , Injections, Intraventricular , Male , Phentolamine/pharmacology , Propranolol/pharmacology , Rats , Rats, Inbred Strains , Somatostatin/pharmacology
9.
FEBS Lett ; 464(1-2): 71-4, 1999 Dec 24.
Article in English | MEDLINE | ID: mdl-10611486

ABSTRACT

Sialic acids are essential components of cell surface receptors used by influenza viruses. To determine the molecular mechanisms of viral recognition of two major species of sialic acids, N-acetylneuraminic acid (Neu5Ac) and N-glycolylneuraminic acid (Neu5Gc), we tested the binding reactivity of nine human H3 influenza A viruses to sialylglycolipids containing type II sugar chain and different molecular species of terminal sialic acids. All human H3 viruses tested except A/Memphis/1/71 bound both Neu5Ac and Neu5Gc. Nucleotide sequence analysis suggests that amino acids at 143, 155, and 158 are linked to the viral recognition of Neu5Gc.


Subject(s)
Hemagglutinins/chemistry , Influenza A virus/chemistry , Neuraminic Acids/metabolism , Sialoglycoproteins/metabolism , Amino Acid Sequence , Carbohydrate Sequence , Chromatography, Thin Layer , Glycoconjugates/metabolism , Humans , Models, Molecular , Molecular Sequence Data , Sequence Homology, Amino Acid , Viral Proteins/metabolism
10.
J Neuroimmunol ; 115(1-2): 199-202, 2001 Apr 02.
Article in English | MEDLINE | ID: mdl-11282171

ABSTRACT

The thymus is a critical organ for the elimination of autoreactive T cells by apoptosis. We studied the expression of apoptosis-associated genes, bcl-xL, bad, caspase-3, and c-myc family genes in myasthenia gravis (MG) thymuses. We observed that the mRNA levels of myc family genes, c-myc and max, were markedly reduced in MG thymuses. These results indicate that c-myc-mediated signaling is abnormal in MG thymuses. The levels of molecules whose expressions are associated with myc, such as STAM, prothymosin-alpha, and NFkappaB, were also analyzed.


Subject(s)
Adaptor Proteins, Signal Transducing , Myasthenia Gravis/metabolism , Proto-Oncogene Proteins c-myc/metabolism , Repressor Proteins , Thymus Gland/metabolism , Transcription Factors , Adult , Apoptosis , Basic Helix-Loop-Helix Leucine Zipper Transcription Factors , Basic-Leucine Zipper Transcription Factors , Carrier Proteins/genetics , Carrier Proteins/metabolism , Caspase 3 , Caspases/genetics , Caspases/metabolism , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Endosomal Sorting Complexes Required for Transport , Female , Humans , Male , Myasthenia Gravis/pathology , NF-kappa B/genetics , NF-kappa B/metabolism , Phosphoproteins/genetics , Phosphoproteins/metabolism , Protein Precursors/genetics , Protein Precursors/metabolism , Proto-Oncogene Proteins c-bcl-2/genetics , Proto-Oncogene Proteins c-bcl-2/metabolism , Proto-Oncogene Proteins c-myc/genetics , Proto-Oncogene Proteins c-rel/genetics , Proto-Oncogene Proteins c-rel/metabolism , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction , T-Lymphocytes/immunology , T-Lymphocytes/pathology , Thymosin/analogs & derivatives , Thymosin/genetics , Thymosin/metabolism , Thymus Gland/pathology , Transcription Factor RelA , bcl-Associated Death Protein , bcl-X Protein
11.
Ann Thorac Surg ; 50(2): 243-7, 1990 Aug.
Article in English | MEDLINE | ID: mdl-2383110

ABSTRACT

One hundred sixty-six patients underwent operation for myasthenia gravis between 1977 and 1989. Thirty-eight patients had associated thymoma, registering stages I (n = 17), II (n = 9), III (n = 11), and IVa (n = 1) according to the classification of Masaoka and colleagues. Extended thymectomy was performed on 128 patients without thymoma; thymothymectomy, with resection of the anterior mediastinal fat and tissues adherent to the tumor, was performed in all patients with thymoma. There were no instances of early or late death. Neuromuscular function improved, and clinical myasthenic symptoms stabilized in almost all patients except 2 patients in stage III and 1 patient in stage IVa, who had an exacerbation of the myasthenic symptoms associated with recurrence of thymoma. All the recurrent tumors were on the pleura and could be resected. The suspected cause of recurrence is either dissemination of tumor cells as a result of operative manipulation or undetected disseminated foci that existed at the time of the first operation. The resections of the recurrent invasive thymomas localized on the pleura were easily performed and improved the myasthenic symptoms.


Subject(s)
Myasthenia Gravis/etiology , Pleural Neoplasms/secondary , Thymectomy , Thymoma/secondary , Thymus Neoplasms/surgery , Adult , Female , Humans , Male , Middle Aged , Pleural Neoplasms/surgery , Thymoma/complications , Thymoma/surgery , Thymus Neoplasms/complications , Time Factors
12.
Brain Res ; 887(1): 183-6, 2000 Dec 22.
Article in English | MEDLINE | ID: mdl-11134603

ABSTRACT

In the present study, we have demonstrated that multiple first-generation H1-antagonists caused behavioral and EEG seizures in rats. The epileptogenic property of pyrilamine was more potent than either chlorpheniramine or diphenhydramine. In contrast, the second-generation H1-antagonists, loratadine and ebastine did not induce detectable epileptogenic activity. Intraperitoneal injection of histidine inhibited the EEG seizures induced by pyrilamine, diphenhydramine or chlorpheniramine; however no antagonism was observed with physostigmine. These results clearly suggest that the epileptogenic activity of first-generation H1-antagonists is dependent upon a centrally acting histaminergic mechanism.


Subject(s)
Electroencephalography/drug effects , Histamine H1 Antagonists/pharmacology , Seizures/chemically induced , Animals , Cholinesterase Inhibitors/pharmacology , Histidine/pharmacology , Male , Physostigmine/pharmacology , Rats , Rats, Wistar
13.
Brain Dev ; 6(5): 458-66, 1984.
Article in English | MEDLINE | ID: mdl-6083732

ABSTRACT

In these past 10 years, the usefulness of auditory brainstem response (ABR) has been demonstrated in the clinical evaluation of audiological or neurological disorders, and the absence of an ABR is commonly accepted as consistent with a peripheral hearing loss caused by middle or inner ear diseases. In this article, the authors report nine infants and children who had an absent or difficult to detect ABR at the first examination with subsequent normalization of ABR. Repeated otological examinations were always normal in these patients. The final diagnoses were delayed development, Waardenburg syndrome with congenital heart disease and epilepsy, healthy infant, infantile convulsion, mental retardation with history of low birth weight, in each case, and chromosomal aberration in four patients. The reason for normalization of ABR in our patients is not clear and is yet to be ascertained. However, the authors believe that neurological maturation rather than an improved primary peripheral disorder is responsible for the noted normalization of the ABR, because of the high incidence of neurological abnormalities in these patients.


Subject(s)
Auditory Perception/physiology , Brain Stem/physiopathology , Child Development , Hearing Loss, Sensorineural/diagnosis , Audiometry, Evoked Response , Auditory Threshold/physiology , Chromosome Aberrations/diagnosis , Chromosome Disorders , Developmental Disabilities/diagnosis , Down Syndrome/diagnosis , Female , Follow-Up Studies , Hearing Loss, Sensorineural/physiopathology , Heart Defects, Congenital/diagnosis , Humans , Infant , Infant, Low Birth Weight , Infant, Newborn , Male , Reaction Time/physiology , Spasms, Infantile/diagnosis , Waardenburg Syndrome/diagnosis
14.
Clin Neuropathol ; 3(4): 178-84, 1984.
Article in English | MEDLINE | ID: mdl-6478680

ABSTRACT

A two year and ten-month-old girl with cerebello-brain stem leukodystrophy is presented. She was hypotonic with spasticity and showed delayed motor development until she was twelve months old, when regression of motor activities began. Progressive hypotonia, dysphagia and fatal respiratory abnormalities developed. Auditory brain stem response was absent. Pathological examination revealed primary demyelination with a predilection for the cerebellum, brain stem and spinal cord, in association with changes of the cerebellar cortex, pontine nuclei, inferior olivary nuclei and part of the basal ganglia. Clinical, pathological and biochemical studies revealed that this disease is different from metachromatic leukodystrophy, Krabbe's globoid cell leukodystrophy and adrenoleukodystrophy. The clinical entity of cerebello-brain stem orthochromatic leukodystrophy is discussed.


Subject(s)
Brain Stem/pathology , Bulbar Palsy, Progressive/pathology , Cerebellum/pathology , Diffuse Cerebral Sclerosis of Schilder/pathology , Muscle Hypotonia/pathology , Female , Humans , Infant , Leukodystrophy, Globoid Cell/pathology , Spinal Cord/pathology , Syndrome
15.
Rinsho Shinkeigaku ; 41(4-5): 179-83, 2001.
Article in Japanese | MEDLINE | ID: mdl-11676158

ABSTRACT

A patient was a fifty-year-old man, who had a 35 year-history of facioscapulohumeral muscular dystrophy (FSHD). He was admitted to our hospital because of acute progressive weakness involving his lower extremities without any fluctuation in the recent 3 weeks. We clinically followed him for 30 years and he was able to do all daily activities, walked alone, drove a car and climbed stairs with a handrail. His 76-year-old mother had about 60 year-history of FSHD and could walk with support. On admission, neurological examination revealed moderate to marked muscle weakness and atrophy of the face, limb-girdle and all extremities, predominantly in the upper proximal limbs. He could hardly stand and needed a stick for walking. He had no blepharoptosis or ocular movement disturbance, and did not complain of difficulties in swallowing and chewing. CK values and other laboratory data were normal, and serum anti-Jo-1 antibody, anti-SSA/Ro antibody and anticardiolipin IgG antibody were negative. Because EMG examination revealed myopathic changes and an X-ray examination of the lumbar spine was normal. Thus, polymyositis and neurologenic disorders were ruled out. Disturbance in chewing and swallowing, that were uncommon in FSHD, appeared about a month after admission. Repetitive stimulation test revealed typical waning pattern. Edrophonium chloride injection was effective for decreased waning and the clinical symptoms. The titer of serum anti-ACh receptor antibody was 97 nmol/l, confirming the diagnosis of myasthenia gravis. Because of fluctuated dyspnea, thymectomy was done and his condition gradually relieved after administration of corticosteroid and choline esterase inhibitor. From this experience, we learned that we have to consider other neuromuscular disorders, even rare ones, if there existed unusual weakness of underlying muscular dystrophy.


Subject(s)
Muscular Dystrophy, Facioscapulohumeral/complications , Myasthenia Gravis/complications , Myasthenia Gravis/diagnosis , Aged , Cholinesterase Inhibitors/therapeutic use , Female , Humans , Male , Middle Aged , Muscular Dystrophy, Facioscapulohumeral/diagnosis , Muscular Dystrophy, Facioscapulohumeral/genetics , Myasthenia Gravis/therapy , Prednisolone/administration & dosage , Thymectomy , Treatment Outcome
16.
No To Shinkei ; 53(8): 723-7, 2001 Aug.
Article in Japanese | MEDLINE | ID: mdl-11577413

ABSTRACT

From June 1975 to March 1999, 300 patients of myasthenia gravis(MG) have undergone thymectomy. Among these patients, 69 cases were classified as ocular type of MG(including 15 cases with thymoma), and 231 were generalized type of MG(including 86 cases with thymoma). The efficacy of the treatment was investigated by evaluating current patients' life activity, which is classified in 6 groups(Remission, Much Improved, Improved, Unchanged, Worse, and Died). Among the 214 cases without thymoma, Remission was 75, Much Improved was 56, and Improved was 55, namely 86.9% of these cases showed Improved or better. Among 86 cases with thymoma, Remission was 14, Much Improved was 21, and Improved was 32, namely 77.9% of these cases showed Improved or better. We concluded that post-operative outcome of these patients regardless of thymoma were generally satisfactory, but it was necessary to carry out long term careful follow-up.


Subject(s)
Myasthenia Gravis/surgery , Thymectomy , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Evaluation Studies as Topic , Female , Follow-Up Studies , Humans , Infant , Male , Middle Aged , Myasthenia Gravis/complications , Remission Induction , Thymoma/complications , Thymus Neoplasms/complications
17.
Kyobu Geka ; 45(12): 1109-12, 1992 Nov.
Article in Japanese | MEDLINE | ID: mdl-1405135

ABSTRACT

A seven-month-old baby with double aortic arch was reported. He was admitted to our hospital with complaint of frequent respiratory infections shortly after birth. On examination, bronchofiberscopy revealed compression of the trachea and left main bronchus from behind and angiography showed complete vascular ring, namely double aortic arch with no other cardiac anomaly. Soon after the operation, stridor disappeared at rest, but mild stridor persisted on exertion. Three months later, he was re-admitted to our hospital because of pneumonia. Therefore, close observation is required for the patients with double aortic arch, even if the operation is effective.


Subject(s)
Aorta, Thoracic/abnormalities , Aorta, Thoracic/surgery , Respiratory Tract Infections/complications , Humans , Infant , Male , Prognosis
18.
Kyobu Geka ; 55(11): 981-5, 2002 Oct.
Article in Japanese | MEDLINE | ID: mdl-12391697

ABSTRACT

From June 1975 to March 2002, we experienced 339 patients with myasthenia gravis (MG). Ninety-four patients (81 generalized MG and 13 ocular type) had associated with thymoma. Extended thymectomy including thymoma was performed in all patients. The thymomas were classified as stage I (n = 46), II (n = 31), III (n = 14), and IV a (n = 3). Histopathological findings of the thymoma indicated polygonal cell type in 75 cases, mixture of polygonal and spindle cell type in 14, and spindle cell type in 3, respectively. Three cases in stage II, 12 in III, and 3 in IV a received postoperative radiation therapy. Twenty-two patients required prolonged respirator management for respiratory crisis. Complete remission of MG was seen in 15 cases (17%), and good therapeutic results were obtained in 55 cases (58%) with combined corticosteroid therapy. On the other hand, recurrences of the invasive thymoma were seen in 12 cases (13%), and six of them (6%) died of the tumor. In conclusion, early extended thymectomy including thymoma is markedly effective therapy for MG associated with thymoma, although careful attention should be paid for recurrence of the invasive thymoma.


Subject(s)
Myasthenia Gravis/surgery , Thymectomy , Thymoma/complications , Thymus Neoplasms/complications , Adult , Aged , Combined Modality Therapy , Female , Humans , Male , Middle Aged , Myasthenia Gravis/etiology , Prognosis , Remission Induction , Retrospective Studies , Sex Distribution , Thymoma/therapy , Thymus Neoplasms/therapy , Treatment Outcome
19.
Kyobu Geka ; 46(1): 48-53, 1993 Jan.
Article in Japanese | MEDLINE | ID: mdl-8418360

ABSTRACT

From June 1975 to June 1992, we experienced 203 patients with MG. Sixty patients had associated thymoma, registering stages I (n = 31), II (n = 18), III (n = 9), and IV a (n = 2), according to the classification of Masaoka and colleagues. Fifty patients had generalized MG and 10 had ocular MG. Histopathological findings indicated round-oval, polygonal cell type in 46 patients and mixture of round-oval and spindle cell type in 11 patients and invasive thymomas had a tendency to have a predominantly epithelial type with and increased epithelial element as compared with non-invasive thymomas. An extended thymectomy including thymoma was performed in all patients. Three patients in stage II, 7 patients in stage III, and 2 patients in IV a received postoperative radiation therapy. Twenty-one patients needed prolonged respiratory care for respiratory crisis. Fifty-three patients have been doing well with the alternate-day corticosteroid therapy, however, 4 patients had an excavation of myasthenic symptoms associated with recurrence of thymoma on the pleura. In conclusion, early extended thymectomy including thymoma is markedly effective therapy for MG with thymoma and a careful attention should be paid for recurrence in the patients with invasive thymoma.


Subject(s)
Myasthenia Gravis/surgery , Thymectomy , Thymoma/complications , Thymus Neoplasms/complications , Adult , Aged , Combined Modality Therapy , Female , Humans , Male , Middle Aged , Myasthenia Gravis/etiology , Thymoma/radiotherapy , Thymoma/surgery , Thymus Neoplasms/radiotherapy , Thymus Neoplasms/surgery
20.
Kyobu Geka ; 55(2): 149-54, 2002 Feb.
Article in Japanese | MEDLINE | ID: mdl-11842554

ABSTRACT

Aneurysm of the ductus arteriosus is rare, however, reports on this lesion have increased recently with the progress of thoracic aortic surgery in Japan. We report 3 male cases aged 58, 59, 73 years. Aneurysms and total aortic arch were replaced by artificial graft through median sternotomy using selective cerebral perfusion in 2 cases. Through left posterolateral thoracotomy using deep hypothermia with circulatory arrest, proximal descending thoracic aorta including the aneurysm was replaced in 1 case. Their postoperative courses were uneventful. Surgery for this lesion is safe and various surgical approaches and circulatory supporting methods can be selected depending on the size of aneurysm and associated lesions.


Subject(s)
Aneurysm/surgery , Aortic Aneurysm, Thoracic/surgery , Ductus Arteriosus , Aged , Aorta, Thoracic/surgery , Blood Vessel Prosthesis Implantation , Ductus Arteriosus/surgery , Ductus Arteriosus, Patent/surgery , Humans , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL